I maxi-compensi? Una malattia.
Interview to John Wilcox on the controversial issue of executive remuneration and the voicing of shareholder discontent at some Shareholder Meetings in UK and US.
Related News
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right